![Douglas Williamson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Williamson
Director/Board Member at
VISTAGEN THERAPEUTICS, INC.
Profile
Douglas J.
Williamson is currently an Independent Director at Vistagen Therapeutics, Inc. since 2026 and a Member of The Royal College of Psychiatrists.
Former roles include Independent Director at Bright Minds Biosciences, Inc. from 2022 to 2023, Head-Early Phase Clinical Development Neuroscience at Eli Lilly & Co., Vice President & Global Head-Therapeutic at PAREXEL International Corp., Senior VP, Head-US Research & Development at H.
Lundbeck A, Chief Medical Officer at Avadel Pharmaceuticals Plc, Executive VP, Head-Research & Development at ACADIA Pharmaceuticals, Inc., and Chief Medical Officer at QurAlis Corp.
Education includes a doctorate from The University of Edinburgh.
Douglas Williamson active positions
| Companies | Position | Start |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Director/Board Member | 29/07/2026 |
The Royal College of Psychiatrists
 The Royal College of Psychiatrists Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | - |
Former positions of Douglas Williamson
| Companies | Position | End |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Director/Board Member | 09/01/2023 |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Chief Tech/Sci/R&D Officer | - |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
| ACADIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Training of Douglas Williamson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
26
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Psychiatrists
The Royal College of Psychiatrists Financial ConglomeratesFinance Provides investment services | Finance |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
Avadel Pharmaceuticals Plc
 Avadel Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Health Technology |
Bright Minds Biosciences, Inc.
 Bright Minds Biosciences, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
- Stock Market
- Insiders
- Douglas Williamson
